Mukundan to Lead CII; Ella Named President-Designate for 2026-27

ECONOMY
Whalesbook Logo
AuthorAkshat Lakshkar|Published at:
Mukundan to Lead CII; Ella Named President-Designate for 2026-27
Overview

R. Mukundan, MD & CEO of Tata Chemicals, will lead the Confederation of Indian Industry (CII) as President for 2026-27. Suchitra K. Ella, Co-founder & MD of Bharat Biotech, has been appointed President-Designate. Shashwat Goenka, Vice Chairman of RP-Sanjiv Goenka Group, takes on the role of Vice President. These appointments at India's premier industry association signal upcoming strategic priorities and policy engagements.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

New Leadership at CII for 2026-27

The Confederation of Indian Industry (CII) has appointed R. Mukundan, the Managing Director & CEO of Tata Chemicals, as its President for the 2026-27 term. This move places a seasoned industry veteran at the helm of one of India's most influential business associations. Mukundan's extensive career within the Tata Group, spanning over three decades across various sectors, brings a wealth of experience to the role.

Key Appointments Signal Strategic Direction

Suchitra K. Ella, the Co-founder and Managing Director of Bharat Biotech, has been elected as the CII President-Designate. Ella, a recipient of the Padma Bhushan, is renowned for her contributions to the biotechnology sector, particularly in vaccine development. Shashwat Goenka, Vice Chairman of the RP-Sanjiv Goenka Group and a recognized Young Global Leader, will serve as the CII Vice President. Goenka's prior experience, including chairing the CII Eastern Region, positions him to contribute significantly.

Industry Body's Role and Future Focus

These leadership transitions are critical for CII's role in shaping India's economic and industrial policy. The diverse expertise of Mukundan in chemicals, Ella in biotech and healthcare, and Goenka in diversified business operations is expected to guide the association's agenda. CII's advocacy efforts will likely focus on areas such as manufacturing competitiveness, sustainable development, and innovation, influencing the broader business environment and contributing to India's growth trajectory.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.